t
On 17 August 2026, Duke Capital Limited's Remuneration Committee granted a total of 4,589,000 conditional performance share awards, with Neil Johnson and Charlie Cannon Brookes each receiving 1,222,000. Concurrently, 1,225,911 previously granted PSAs from the financial years ended 31 March 2023 and 31 March 2025 vested, resulting in the transfer of shares from the Employee Benefit Trust (EBT) to beneficiaries, of which 150,000 shares were sold on 14 August 2026 at 27.55 pence to cover tax. Duke Capital also issued 1,552,857 new ordinary shares into its EBT, expected to be admitted to AIM on 18 August 2026, bringing the total ordinary shares in issue to 511,368,630.
| Date | 17 Aug 2026 |
| Time | 07:00:08 |
| Category | Director/PDMR dealings |
| ID | 8400Q |
17 August 2026
Duke Capital Limited
("Duke Capital", "Duke" or the "Company")
Performance Share Awards
Director/PDMR Dealings and Issue of Equity
Duke Capital Limited (AIM: DUKE), a leading provider of hybrid capital solutions for SME business owners in Europe and North America, announces that the Company's Remuneration Committee has approved the grant of a total of 4,589,000 conditional rights to acquire ordinary shares of no par value (“PSAs”) under the Company's Long-Term Incentive Plan ("LTIP").
PSAs for the financial year to 31 March 2026 have been granted as follows:
|
Neil Johnson |
1,222,000 |
|
Charlie Cannon Brookes |
1,222,000 |
|
Other employees (non-PDMRs) |
2,145,000 |
|
Total |
4,589,000 |
The PSAs vest after a period of three years and are subject to various performance conditions outlined in the Company's admission document (and available on the Company's website) and set by the Remuneration Committee, all in accordance with the LTIP rules. The PSAs will be subject to the following conditions:
Vesting of PSAs, transfer from Employee Benefit Trust (“EBT”) & Director/PDMR interests
The Company announces that a total of 453,745 PSAs, previously granted under the Company's LTIP in relation to the financial year ended 31 March 2023 have vested, representing 12.4% of the PSAs granted at that time.
The Company also announces that a total of 772,166 PSAs, previously granted under the Company's LTIP in relation to the financial year ended 31 March 2025 have vested, representing 16.7% of the PSAs granted at that time.
Accordingly, 1,225,911 existing ordinary shares held within the EBT have now been transferred to the beneficiaries, of which 150,000 shares have been sold at a price of approximately 27.55 pence in order to meet certain tax liabilities arising upon issue of the PSAs. Further information is set out within the PDMR notification tables below.
Following the various transactions detailed above, the following Directors / PDMRs have the following total interest in ordinary shares:
|
Director/PDMR |
Total ordinary shares held |
|
Neil Johnson (1) |
8,066,427 |
|
Charlie Cannon Brookes (2) |
13,637,148 |
(1) Mr Johnson is Abingdon Capital Corporation's sole voting shareholder which legally owns 2,123,149 ordinary shares included within this figure.
(2) Mr Cannon Brookes a Director and shareholder of Arlington Asset Management Limited ("Arlington"). This figure includes 5,818,181 ordinary shares legally owned by Arlington.
Total voting rights and EBT share issue
In order to maintain an appropriate level of headroom within the Company's EBT, the Company has issued 1,552,857 new ordinary shares into the Duke Capital EBT, ownership of which shall be transferred, in part or in full, to individual beneficiaries, subject to achievement of the relevant criteria following the vesting period. Application has been made for these 1,552,857 shares to be admitted to trading on AIM, which is expected to occur on 18 August 2026 ("Admission").
Following Admission and transfer of the 1,225,911 shares to LTIP beneficiaries, the Company will have 511,368,630 ordinary shares in issue admitted to trading on AIM, of which 6,626,313 will be held by the EBT. This figure (511,368,630) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
For further information, please visit www.dukecapital.com or contact:
|
Duke Capital Limited |
Neil Johnson / Charles Cannon Brookes / Hugo Evans
|
+44 (0) 1481 231 816 |
|
Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker) |
Stephen Keys / Callum Davidson / Michael Johnson |
+44 (0) 207 220 0500
|
|
|
|
|
|
Canaccord Genuity Limited (Joint Broker)
|
Adam James / Harry Rees |
+44 (0) 207 523 8000 |
Notifications of dealings by PDMRs:
|
1. |
Details of the person discharging managerial responsibilities/persons closely associated |
|||||
|
a) |
Name |
Neil Johnson |
||||
|
2. |
Reason for notification |
|||||
|
a) |
Position/Status |
Chief Executive Officer |
||||
|
b) |
Initial notification/amendment |
Initial |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Duke Capital Limited |
||||
|
b) |
LEI |
213800GUTKPSJ39SER44 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument and identification code |
Ordinary shares of nil par value GG00BYZSSY63 |
||||
|
b) |
Nature of transaction |
Grant of conditional performance share awards under LTIP |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated Information |
n/a |
||||
|
e) |
Date of transaction |
Award date: 17 August 2026 |
||||
|
f) |
Place of transaction |
Outside a trading venue |
||||
|
1. |
Details of the person discharging managerial responsibilities/persons closely associated |
|||||
|
a) |
Name |
Neil Johnson |
||||
|
2. |
Reason for notification |
|||||
|
a) |
Position/Status |
Chief Executive Officer |
||||
|
b) |
Initial notification/amendment |
Initial |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Duke Capital Limited |
||||
|
b) |
LEI |
213800GUTKPSJ39SER44 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument and identification code |
Ordinary shares of nil par value GG00BYZSSY63 |
||||
|
b) |
Nature of transaction |
Acquisition of ordinary shares following vesting of conditional performance share awards under LTIP |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated Information |
n/a |
||||
|
e) |
Date of transaction |
17 August 2026 |
||||
|
f) |
Place of transaction |
Outside a trading venue |
||||
|
1. |
Details of the person discharging managerial responsibilities/persons closely associated |
|||||||
|
a) |
Name |
Neil Johnson |
||||||
|
2. |
Reason for notification |
|||||||
|
a) |
Position/Status |
Chief Executive Officer |
||||||
|
b) |
Initial notification/amendment |
Initial |
||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name |
Duke Capital Limited |
||||||
|
b) |
LEI |
213800GUTKPSJ39SER44 |
||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument and identification code |
Ordinary shares of nil par value GG00BYZSSY63 |
||||||
|
b) |
Nature of transaction |
Sale of ordinary shares following vesting of conditional performance share awards under LTIP to cover tax liability |
||||||
|
c) |
Price(s) and volume(s) |
|
||||||
|
d) |
Aggregated Information |
N/A – single transaction |
||||||
|
e) |
Date of transaction |
14 August 2026 |
||||||
|
f) |
Place of transaction |
London Stock Exchange - AIM |
||||||
|
1. |
Details of the person discharging managerial responsibilities/persons closely associated |
|||||
|
a) |
Name |
Charlie Cannon Brookes |
||||
|
2. |
Reason for notification |
|||||
|
a) |
Position/Status |
Chief Investment Officer |
||||
|
b) |
Initial notification/amendment |
Initial |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Duke Capital Limited |
||||
|
b) |
LEI |
213800GUTKPSJ39SER44 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument and identification code |
Ordinary shares of nil par value GG00BYZSSY63 |
||||
|
b) |
Nature of transaction |
Grant of conditional performance share awards under LTIP |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated Information |
n/a |
||||
|
e) |
Date of transaction |
Award date: 17 August 2026 |
||||
|
f) |
Place of transaction |
Outside a trading venue |
||||
|
1. |
Details of the person discharging managerial responsibilities/persons closely associated |
|||||
|
a) |
Name |
Charlie Cannon Brookes |
||||
|
2. |
Reason for notification |
|||||
|
a) |
Position/Status |
Chief Investment Officer |
||||
|
b) |
Initial notification/amendment |
Initial |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Duke Capital Limited |
||||
|
b) |
LEI |
213800GUTKPSJ39SER44 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument and identification code |
Ordinary shares of nil par value GG00BYZSSY63 |
||||
|
b) |
Nature of transaction |
Acquisition of ordinary shares following vesting of conditional performance share awards under LTIP |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated Information |
n/a |
||||
|
e) |
Date of transaction |
17 August 2026 |
||||
|
f) |
Place of transaction |
Outside a trading venue |
||||